D-Index & Metrics Best Publications

Irene L. Andrulis

University of Toronto
Canada

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 106 Citations 42,284 507 World Ranking 3817 National Ranking 152

Best female scientists D-index 106 Citations 42,285 508 World Ranking 686 National Ranking 21

Research.com Recognitions

Awards & Achievements

2023 - Research.com Best Female Scientist Award

2022 - Research.com Best Female Scientist Award

Overview

What are the main themes of her work throughout her whole career to date

Irene L. Andrulis applies her multidisciplinary studies on Cancer and Prostate in her research. She conducted interdisciplinary study in her works that combined Prostate and Cancer. She merges many fields, such as Genetics and Computational biology, in her writings. She integrates Computational biology and Gene in her studies. She integrates many fields, such as Gene and Heritability, in her works. She integrates many fields in her works, including Heritability and Genotype. Irene L. Andrulis conducted interdisciplinary study in her works that combined Genotype and Single-nucleotide polymorphism. Single-nucleotide polymorphism and Linkage disequilibrium are two areas of study in which she engages in interdisciplinary research. Her study connects Genetics and Linkage disequilibrium.

Irene L. Andrulis most often published in these fields:

Cancer (87.50%)
Genetics (87.50%)
Gene (87.50%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Karoline B. Kuchenbaecker;Karoline B. Kuchenbaecker;John L. Hopper;Daniel R. Barnes;Kelly-Anne Phillips.
JAMA (2017)

1731 Citations

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)

1179 Citations

MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

Kolja Eppert;Stephen W Scherer;Hilmi Ozcelik;Rosa Pirone.
Cell (1996)

1112 Citations

Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.

K. E. Noonan;C. Beck;T. A. Holzmayer;J. E. Chin.
Proceedings of the National Academy of Sciences of the United States of America (1990)

1068 Citations

RAD51B in Familial Breast Cancer

Liisa M. Pelttari;Sofia Khan;Mikko Vuorela;Johanna I. Kiiski.
PLOS ONE (2016)

1014 Citations

Association analysis identifies 65 new breast cancer risk loci

Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Nature (2017)

969 Citations

Breast-Cancer Risk in Families with Mutations in PALB2

A. C. Antoniou;S. Casadei;T. Heikkinen;D. Barrowdale.
The New England Journal of Medicine (2014)

907 Citations

HER2 and responsiveness of breast cancer to adjuvant chemotherapy.

Kathleen I. Pritchard;Lois E. Shepherd;Frances P. O'Malley;Irene L. Andrulis.
The New England Journal of Medicine (2006)

708 Citations

MicroRNA related polymorphisms and breast cancer risk

Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne.
PLOS ONE (2014)

629 Citations

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek.
Cancer Epidemiology, Biomarkers & Prevention (2012)

616 Citations

If you think any of the details on this page are incorrect, let us know.